• Home
  • Leadership
  • Pipeline
  • Investors
  • More
    • Home
    • Leadership
    • Pipeline
    • Investors

  • Home
  • Leadership
  • Pipeline
  • Investors

Our Pipeline

 Tissue-intelligent Medicines 

 

  1. OA Action Alliance. Access www.oaaction.unc.edu​
  2. Osteoarthritis Research Society International (OARSI). Osteoarthritis: a serious disease. White paper submitted to the U.S. FDA; 2016. Accessed at www.oarsi.org ​
  3. Bliddal H, et al. New Engl J Med, 2024: 391(17)​
  4. Wylde V, et al, Pain, 2011: 152 (3)​
  5. Wood MJ, et al. JCI Insight. 2019: 4​
  6. Martel-Pelletier J, et al. Nat Rev Dis Primers. 2016: 2 ​
  7. Robinson WH, et al. Nat Rev Rheumatol. 2016: 12​
  8. Scanzello CR, Goldring SR. Bone. 2012: 51 ​
  9. Berenbaum F, Osteoarthritis Cartilage. 2013: 21​
  10. Schieker M, Conaghan PG, et al. Annals of Internal Medicine, 2020   ​
  11. Ridker PM, et al. New Engl J Med, 2017: 377(12)  (main CANTOS publication) ​
  12. Zhu Y, et al, Arthritis Rheum. 2011: 63 ​
  13. Kuo CF, et al, Nat Rev Rheumatology, 2015: 11​
  14. Lim SY, et al, JAMA. 2016: 315. ​
  15. Wu EQ, et al, J Manag Care Pharm. 2008: 14​
  16. Ruoff G, et al, Postgrad. Med. 2016: 128​
  17. Schlesinger N, et al, J. Rheumatol. 2009: 36​
  18. Terkeltaub, R, et al, Arthritis Res. Ther. 2006: 8, S4 ​
  19. Schlesinger N, et al, Nature Rev. Rheumatology, 2023: 19​
  20. Solomon DH, et al. Annals of Internal Medicine, 2018: 169 (8)


Copyright © 2026 Avalor Therapeutics - All Rights Reserved.

Powered by GoDaddy

  • Home
  • Leadership
  • Pipeline
  • Investors

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept